Clinical Trial Update: Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial is evaluating an adjuvant therapy combining an mRNA vaccine with a PD-1 inhibitor for postoperative, resectable pancreatic cancer;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• PD-1 inhibitor
• mRNA vaccine

Snippet

Sponsor: Ruijin Hospital | Conditions: Pancreatic Cancer Resectable, Chemotherapy-intolerant | EARLY_Phase 1 | Status: RECRUITING